Quest PharmaTech Inc.
QPT.V
TSX
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 122.64% | 121.34% | 119.81% | 120.65% | 24.04% |
| Total Depreciation and Amortization | -100.00% | -100.00% | -42.42% | -79.05% | -86.52% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -123.63% | -122.28% | -120.69% | -121.67% | -24.65% |
| Change in Net Operating Assets | -168.56% | 130.51% | 94.46% | 204.06% | 171.98% |
| Cash from Operations | -22.71% | 12.84% | 20.54% | 40.03% | -17.04% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Investing | -- | -- | -- | 90.00% | -164.71% |
| Total Debt Issued | -100.00% | -100.00% | -- | -60.00% | -73.33% |
| Total Debt Repaid | 100.00% | 100.00% | 100.00% | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 660.78% | 660.78% | 660.78% | 660.78% | -- |
| Cash from Financing | 635.07% | 503.81% | 1,097.12% | -4.07% | -89.57% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 125.20% | 153.63% | 160.69% | 163.25% | -179.50% |